Government news, all in one place
Government news, all in one place
The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.
Based on publicly published press releases (last 12 months)
851 articles
Showing 1-30
Friday, 29 May 2026
The raid on a Northamptonshire estate dismantled what is believed to be a major illicit manufacturing and distribution operation...
Friday, 29 May 2026
As with any medicine, the MHRA will keep the safety and effectiveness of rilzabrutinib under close review. ...
Thursday, 28 May 2026
Patients taking Crescent Pharma Limited Ramipril 2.5mg capsules are advised to check their packaging for batch number GR155023 and contact their pharm...
Wednesday, 27 May 2026
Jason is an experienced technology leader with over 25 years working in tech leadership and health informatics. ...
Tuesday, 26 May 2026
Essential advice on protecting your medicines during extreme heat and staying safe. ...
Wednesday, 20 May 2026
The MHRA launches public consultation on new framework that could lead to earlier licensing for therapies for up to 3.5 million people in the UK....
Wednesday, 20 May 2026
Proposed Rare Disease Therapies Framework introduces Investigational Marketing Authorisation and compressed development pathways – industry urged to r...
Tuesday, 19 May 2026
MHRA announces new programme of events and greater engagement with industries, researchers, local NHS and government in Wales. ...
Monday, 18 May 2026
Innovation doesn’t wait for the rules to catch up. The question is whether we can build a system agile and flexible enough to keep pace....
Friday, 15 May 2026
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review. ...
Wednesday, 13 May 2026
The MHRA hub in Belfast will strengthen collaboration and engagement with local industry, academia and the healthcare sector. ...
Monday, 11 May 2026
Updated safety advice has been issued to strengthen warnings about potential psychiatric and sexual dysfunction linked to finasteride and to provide p...
Monday, 11 May 2026
To future-proof the sector and ensure regulation keeps up with scientific and technological developments, the MHRA is consulting on proposed changes t...
Monday, 11 May 2026
New pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the GB market have been published....
Friday, 08 May 2026
The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in th...
Thursday, 07 May 2026
MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome ...
Thursday, 07 May 2026
MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema...
Thursday, 07 May 2026
MHRA and UK Border Force crack down on the illegal medicines trade in intensive 14-day international operation. ...
Friday, 01 May 2026
As with all medicines, we will continue to closely monitor the safety and effectiveness of linerixibat as it is used more widely....
Thursday, 30 April 2026
The MHRA has limited the use of nasal decongestant sprays containing xylometazoline and oxymetazoline to a maximum of five days due to side effects of...
Wednesday, 29 April 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) is pleased to announce the appointment of Jason Bonander as its new Chief Digital and T...
Wednesday, 29 April 2026
An MHRA-led investigation has exposed a £1.8 million illegal medicines and steroids network, leading to seven men being sentenced....
Tuesday, 28 April 2026
The MHRA?has?advised healthcare professionals to?stop supplying the affected?batch of Sertraline 100mg?and?return all remaining stock to their supplie...
Monday, 27 April 2026
Patients in the UK to get access to new treatments faster and still safely under new clinical trial regulations coming into force on 28 April 2026....
Thursday, 23 April 2026
Specific batches of Napralief 250mg Gastro?Resistant Tablets are being recalled because important safety and dosage information is missing from both t...
Wednesday, 22 April 2026
As with any medicine, the MHRA will keep the safety and effectiveness of Enflonsia under close review....
Monday, 20 April 2026
The MHRA?has?advised pharmacy and healthcare professionals to stop supplying the impacted batch and?return all remaining stock to their suppliers....
Wednesday, 15 April 2026
By Dame Jennifer Dixon...
Tuesday, 14 April 2026
As with any medicine, the MHRA will keep the safety and effectiveness of Wegovy under close review....
Monday, 13 April 2026
MHRA and eBay partnership removes 215 listings of potentially dangerous medicines from the eBay platform highlighting the benefits of private/public w...
Department for Environment, Food & Rural Affairs Bluetongue: latest situation
Government Property Agency Major works commence at Great British Energy HQ
Central Arbitration Committee How to submit applications and complaints to the CAC
Prime Minister's Office, 10 Downing Street PM statement on Russian drone hit in Romania: 29 May 2026